Abstract:The antimicrobial peptide LL-37 belongs to the cathelicidin family and is one of the few human bactericidal peptides with potent antistaphylococcal activity. Staphylococcus aureus is one of the main infection bacteria in orthopedic implant therapy. Biofilm formation after bacterial infection brings more and more severe test for clinical antiinfection treatment.However, there are few studies on LL-37 in S. aureus infection of prosthesis. In this work, addition to research the antibacterial activity and the inhi… Show more
“…Thus, an antimicrobial effect of the herein described peptides would be highly beneficial for a future treatment of these critical pathogens. As controls, we included not only MGD2 but also LL37, which was very recently investigated concerning its potency to prevent S. aureus biofilm formation on titanium alloy surfaces 24 . After incubating the peptides for 2 h with the respective strains, a colony formation assay was performed.…”
Section: Resultsmentioning
confidence: 99%
“…As controls, we included not only MGD2 but also LL37, which was very recently investigated concerning its potency to prevent S. aureus biofilm formation on titanium alloy surfaces. 24 After incubating the peptides for 2 h with the respective strains, a colony formation assay was performed. For all tested peptides, a steady decrease in bacterial viability of S. aureus was observed (Figure 2).…”
Bacterial biofilm formation remains a serious problem for clinical materials and often leads to implant failure. To counteract bacterial adhesion, which initiates biofilm formation, the development of antibiotic surface coating strategies is of high demand and warrants further investigations. In this study, we have created bifunctional chimeric peptides by fusing the recently developed antimicrobial peptide MGD2 (GLRKRLRKFFNKIKF) with different titanium‐binding sequences. The novel peptides were investigated regarding their antibacterial potential against a set of different bacterial strains including drug‐resistant Staphylococcus aureus. All peptides showed high antimicrobial activities both when in solution and when immobilized on titanium surfaces. Owing to the ease of synthesis and handling, the herein described peptides might be a true alternative to prevent bacterial biofilm formation.
“…Thus, an antimicrobial effect of the herein described peptides would be highly beneficial for a future treatment of these critical pathogens. As controls, we included not only MGD2 but also LL37, which was very recently investigated concerning its potency to prevent S. aureus biofilm formation on titanium alloy surfaces 24 . After incubating the peptides for 2 h with the respective strains, a colony formation assay was performed.…”
Section: Resultsmentioning
confidence: 99%
“…As controls, we included not only MGD2 but also LL37, which was very recently investigated concerning its potency to prevent S. aureus biofilm formation on titanium alloy surfaces. 24 After incubating the peptides for 2 h with the respective strains, a colony formation assay was performed. For all tested peptides, a steady decrease in bacterial viability of S. aureus was observed (Figure 2).…”
Bacterial biofilm formation remains a serious problem for clinical materials and often leads to implant failure. To counteract bacterial adhesion, which initiates biofilm formation, the development of antibiotic surface coating strategies is of high demand and warrants further investigations. In this study, we have created bifunctional chimeric peptides by fusing the recently developed antimicrobial peptide MGD2 (GLRKRLRKFFNKIKF) with different titanium‐binding sequences. The novel peptides were investigated regarding their antibacterial potential against a set of different bacterial strains including drug‐resistant Staphylococcus aureus. All peptides showed high antimicrobial activities both when in solution and when immobilized on titanium surfaces. Owing to the ease of synthesis and handling, the herein described peptides might be a true alternative to prevent bacterial biofilm formation.
“…The human cathelicidin LL-37 was one of the popular AMPs to be studied during the review period, with LL-37 being one of the few human bactericidal peptides with potent anti-staphylococcal activity (one of the main bacteria associated with orthopeadic implant infections). Using in vitro studies and static biofilm models, Wei et al showed that LL-37 had significant anti-staphylococcal effects and a 'destructive effect' on S. aureus biofilm formed on a titanium alloy surface (as a proxy for a prosthesis) [99]. Wuersching et al examined the effects of LL-37 and human lactoferricin AMPs on anaerobic biofilms associated with oral diseases [100].…”
Microbial biofilm formation creates a persistent and resistant environment in which microorganisms can survive, contributing to antibiotic resistance and chronic inflammatory diseases. Increasingly, biofilms are caused by multi-drug resistant microorganisms, which, coupled with a diminishing supply of effective antibiotics, is driving the search for new antibiotic therapies. In this respect, antimicrobial peptides (AMPs) are short, hydrophobic, and amphipathic peptides that show activity against multidrug-resistant bacteria and biofilm formation. They also possess broad-spectrum activity and diverse mechanisms of action. In this comprehensive review, 150 publications (from January 2020 to September 2023) were collected and categorized using the search terms ‘polypeptide antibiotic agent’, ‘antimicrobial peptide’, and ‘biofilm’. During this period, a wide range of natural and synthetic AMPs were studied, of which LL-37, polymyxin B, GH12, and Nisin were the most frequently cited. Furthermore, although many microbes were studied, Staphylococcus aureus and Pseudomonas aeruginosa were the most popular. Publications also considered AMP combinations and the potential role of AMP delivery systems in increasing the efficacy of AMPs, including nanoparticle delivery. Relatively few publications focused on AMP resistance. This comprehensive review informs and guides researchers about the latest developments in AMP research, presenting promising evidence of the role of AMPs as effective antimicrobial agents.
“…The best-studied NAMP produced in the human body is cathelicidin LL-37, termed host defence enzymes, which possesses antimicrobial and antibiofilm activities against a broad spectrum of MDR strains [ 171 , 217 ]. A large number of studies regarding antimicrobial/antibiofilm properties of the LL-37 are focused on strains in which antibiotic resistance is a serious problem, including P. aeruginosa [ 218 ], S. aureus [ 219 ], S. epidermidis [ 220 ], Streptococcus pneumoniae [ 221 ], Streptococcus pyogenes [ 222 ], Acinetobacter baumannii [ 223 ], E. coli [ 224 ], K. pneumonia [ 225 ], Helicobacter pylori [ 226 ], and Aggregatibacter actinomycetemcomitans [ 227 ]. In P. aeruginosa PAO1 grown under biofilm conditions in a flow cell, global gene expression analysis revealed that 4-day exposure to LL-37 (4 µg/mL) led to the downregulation of 475 genes, including QS-controlled genes such as lasl and rhlR [ 228 ].…”
One of the key mechanisms enabling bacterial cells to create biofilms and regulate crucial life functions in a global and highly synchronized way is a bacterial communication system called quorum sensing (QS). QS is a bacterial cell-to-cell communication process that depends on the bacterial population density and is mediated by small signalling molecules called autoinducers (AIs). In bacteria, QS controls the biofilm formation through the global regulation of gene expression involved in the extracellular polymeric matrix (EPS) synthesis, virulence factor production, stress tolerance and metabolic adaptation. Forming biofilm is one of the crucial mechanisms of bacterial antimicrobial resistance (AMR). A common feature of human pathogens is the ability to form biofilm, which poses a serious medical issue due to their high susceptibility to traditional antibiotics. Because QS is associated with virulence and biofilm formation, there is a belief that inhibition of QS activity called quorum quenching (QQ) may provide alternative therapeutic methods for treating microbial infections. This review summarises recent progress in biofilm research, focusing on the mechanisms by which biofilms, especially those formed by pathogenic bacteria, become resistant to antibiotic treatment. Subsequently, a potential alternative approach to QS inhibition highlighting innovative non-antibiotic strategies to control AMR and biofilm formation of pathogenic bacteria has been discussed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.